Skip to main content
OpenTrials

Clinical trial condition

Metastatic Castration Resistant Prostate Cancer

Explore clinical trials studying Metastatic Castration Resistant Prostate Cancer. Study availability and eligibility vary by location and protocol.

36 public trials 6 recruiting studies
Refine in advanced search Browse all conditions

Metastatic Castration Resistant Prostate Cancer trial results

Completed

Study of TAS3681 in Metastatic Castration Resistant Prostate Cancer

NCT02566772

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • Univeristy of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • Florida Cancer Specialists & Research Institute Sarasota, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • University of Maryland Greenebaum Cancer Center Baltimore, Maryland, United States
View all 33 locations
View Trial Details
Completed

CPI-006 Alone and in Combination With Ciforadenant and With Pembrolizumab for Patients With Advanced Cancers

NCT03454451

Conditions
Adenocarcinoma, Adnexal Diseases, Bladder Cancer, +78 more
Locations
  • Arizona Oncology Tucson, Arizona, United States
  • City Of Hope Duarte, California, United States
  • UC San Francisco San Francisco, California, United States
  • Yale School of Medicine New Haven, Connecticut, United States
View all 27 locations
View Trial Details
Completed

TPST-1120 as Monotherapy and in Combination With Nivolumab in Subjects With Advanced Cancers

NCT03829436

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +58 more
Locations
  • University of California - San Francisco San Francisco, California, United States
  • Miami Cancer Institute Miami, Florida, United States
  • Johns Hopkins University Baltimore, Maryland, United States
  • University of Michigan Rogel Cancer Center Ann Arbor, Michigan, United States
View Trial Details
Completed

A Study of Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency

NCT02952534

Conditions
Mental Retardation, X-Linked, With Or Without Seizures, Arx-Related, Metastatic Castration Resistant Prostate Cancer
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Mayo Clinc Phoenix, Arizona, United States
  • Arizona Oncology Associates Tucson, Arizona, United States
  • Alliance Research Centers Laguna Hills, California, United States
View all 149 locations
View Trial Details
Completed

Phase 1/1b Study to Evaluate the Safety and Tolerability of Ciforadenant Alone and in Combination With Atezolizumab in Advanced Cancers

NCT02655822

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +20 more
Locations
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • University of California - San Francisco San Francisco, California, United States
  • Stanford Cancer Institute Stanford, California, United States
  • Yale University New Haven, Connecticut, United States
View all 20 locations
View Trial Details

Related conditions